Taiwania Capital Activity Every public signal F4 has attached to this firm, with sources and cross-entity links.
Exit
DataPelago, a Taiwania Capital portfolio company, had a portfolio exit on July 16, 2026. DataPelago
Taiwania Capital | Activity | F4 5 investments · SEP 2025 – MAY 2026 Show all
Investment
Taiwania Capital participated in Skeleton Technologies' €33M funding round alongside Axon Partners Group and SmartCap. Skeleton Technologies is an ultracapacitor and SuperBattery manufacturer. Skeleton Technologies
Investment
Taiwania Capital participated in Alcatraz AI's $50M Series B round alongside EBRD and Cogito Capital Partners. Alcatraz AI develops AI-powered facial authentication for access control. Alcatraz AI
Investment
Taiwania's CEE Fund joined Orqa's €12.7 million Series A to support a resilient non-Chinese UAV supply chain. Orqa
Investment
The TaiAx life science joint venture led Rakuten Medical's $100 million Series F. Rakuten Medical
Investment
Taiwania led Supernova's $9.2 million Series A to scale its design-to-code platform. Supernova
Exit
Ambiq, a Taiwania Capital portfolio company, got listed on the New York Stock Exchange (NYSE) in July 2025. Ambiq
New Fund
Taiwania and Axil Capital launched TaiAx Life Science Fund L.P. to back life science innovation. TaiAx Life Science Fund L.P.
Exit
Repligen announced an agreement to acquire Tantti Laboratory, marking a portfolio exit. Tantti Laboratory
Investment
Taiwania made a strategic investment in TransferGo to support Asia-Pacific growth. TransferGo
Investment
Taiwania led APrevent Medical's $6 million Series D funding round. APrevent Medical